Skip to main content
. 2022 Oct 3;10(10):1660. doi: 10.3390/vaccines10101660

Table 3.

Non-allergic and non-toxic antigenic CTL epitopes (with respective antigenic scores) selected for designing the multi-epitope vaccine construct.

S No Start Peptide Epitope Supertype Antigenicity Score (On Vaxijen V2.0)
1 899 MLDMYSVML A2 0.5626
2 467 RQLLFVVEV A2 0.816
3 654 RLANECAQV A2 0.9246
4 784 SVLYYQNNV A2 0.5524
5 365 RLSFKELLV A2 0.864
6 366 LSFKELLVY A3 0.723
7 409 TVKPGNFNK A3 1.378
8 10 RVCGVSAAR A3 0.608
9 585 ATVVIGTSK A3 0.757
10 543 NLKYAISAK A3 1.351
11 365 RLSFKELLV A3 0.864
12 341 VVSTGYHFR A3 1.474
13 890 KLHDELTGH A3 0.4147
14 581 ATRGATVVI B7 0.569
15 242 MPILTLTRA B7 0.806
16 579 IAATRGATV B7 0.8883
17 399 AALTNNVAF B7 0.638
18 528 FAYTKRNVI B7 1.0296